Raymond James Financial Services Advisors, Inc. Amphastar Pharmaceuticals, Inc. Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 9,517 shares of AMPH stock, worth $345,467. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,517
Previous 10,389
8.39%
Holding current value
$345,467
Previous $415,000
11.08%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AMPH
# of Institutions
285Shares Held
34.9MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$216 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$98.4 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$77.5 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$70.7 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$58.6 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.78B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...